Clinical Trial Update: A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) [Phase 4]

View source ↗

Summary

A Phase 4, single-arm study assessing telbivudine with or without add-on tenofovir in adults with HBeAg-positive chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tyzeka (telbivudine)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED